.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,294,615

« Back to Dashboard

Summary for Patent: 5,294,615

Title: Terazosin polymorph and pharmaceutical composition
Abstract:A novel anhydrous crystalline polymorph of 1-(4-amino-6,7-dimethoxy- 2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine monohydrochloride is disclosed, together with pharmaceutical formulations containing the compound. The novel polymorph exhibits a diminished food effect when administered to human subjects.
Inventor(s): Meyer; Glenn A. (Waukegan, IL), Bauer; John F. (Lake Bluff, IL)
Assignee: Abbott Laboratories (Abbott Park, IL)
Application Number:08/090,721
Patent Claim Types:
see list of patent claims
Compound; Composition; Dosage form; Use;

No matches for this query

Premature patent expiration for: 5,294,615

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
5,294,615 March 15, 2006

International Patent Family for Patent: 5,294,615

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria130853<disabled in preview>
Austria182592<disabled in preview>
Canada2107382<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc